| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | sarcomere | 4.83e-05 | 249 | 34 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 7.47e-05 | 273 | 34 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.93e-05 | 290 | 34 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | I band | 1.48e-04 | 166 | 34 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | Z disc | 1.88e-03 | 151 | 34 | 3 | GO:0030018 | |
| Domain | FERM_central | 3.38e-03 | 49 | 33 | 2 | IPR019748 | |
| Domain | FERM_domain | 3.38e-03 | 49 | 33 | 2 | IPR000299 | |
| Domain | FERM_1 | 3.52e-03 | 50 | 33 | 2 | PS00660 | |
| Domain | FERM_2 | 3.52e-03 | 50 | 33 | 2 | PS00661 | |
| Domain | Band_41_domain | 3.52e-03 | 50 | 33 | 2 | IPR019749 | |
| Domain | B41 | 3.52e-03 | 50 | 33 | 2 | SM00295 | |
| Domain | FERM_3 | 3.52e-03 | 50 | 33 | 2 | PS50057 | |
| Domain | PH_dom-like | 6.47e-03 | 426 | 33 | 4 | IPR011993 | |
| Domain | PH | 7.57e-03 | 229 | 33 | 3 | PF00169 | |
| Domain | - | 9.41e-03 | 746 | 33 | 5 | 3.40.50.300 | |
| Domain | Nucleotide-bd_a/b_plait | 1.05e-02 | 258 | 33 | 3 | IPR012677 | |
| Domain | PH | 1.28e-02 | 278 | 33 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 1.29e-02 | 279 | 33 | 3 | PS50003 | |
| Domain | PH_domain | 1.31e-02 | 280 | 33 | 3 | IPR001849 | |
| Domain | P-loop_NTPase | 1.57e-02 | 848 | 33 | 5 | IPR027417 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 27381056 | ||
| Pubmed | Def-2, -3, -6 and -8, novel mouse genes differentially expressed in the haemopoietic system. | 2.74e-05 | 8 | 35 | 2 | 10460589 | |
| Pubmed | NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. | 5.38e-05 | 11 | 35 | 2 | 23219391 | |
| Pubmed | 3.06e-04 | 130 | 35 | 3 | 12421765 | ||
| Pubmed | 5.70e-04 | 1049 | 35 | 6 | 27880917 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.03e-04 | 736 | 35 | 5 | 29676528 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.99e-03 | 50 | 24 | 2 | 1293 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.47e-03 | 206 | 24 | 3 | 682 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 4.73e-05 | 301 | 35 | 5 | M45708 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 7.13e-05 | 167 | 35 | 4 | M2995 | |
| Coexpression | EGFR_UP.V1_UP | 1.22e-04 | 192 | 35 | 4 | M2634 | |
| Coexpression | MEK_UP.V1_UP | 1.30e-04 | 195 | 35 | 4 | M2725 | |
| Coexpression | GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP | 1.38e-04 | 198 | 35 | 4 | M8377 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP | 1.38e-04 | 198 | 35 | 4 | M5152 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP | 1.38e-04 | 198 | 35 | 4 | M5215 | |
| Coexpression | PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2 | 1.38e-04 | 75 | 35 | 3 | M2414 | |
| Coexpression | GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN | 1.40e-04 | 199 | 35 | 4 | M5065 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 1.40e-04 | 199 | 35 | 4 | M9595 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN | 1.43e-04 | 200 | 35 | 4 | M8403 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.43e-04 | 200 | 35 | 4 | M9889 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|metastatic_Brain / Location, Cell class and cell subclass | 7.40e-06 | 160 | 35 | 4 | bc86c6ba1b7815ab944e1ec9da703f469373b8b1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.56e-06 | 166 | 35 | 4 | 26f3d5e5e30b63b09b89cda23c423d12d887631f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.84e-06 | 172 | 35 | 4 | 2b0333c21b7472194a7b9feb3de121da3340fc5b | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 174 | 35 | 4 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 175 | 35 | 4 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-Treg|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-05 | 176 | 35 | 4 | 2eb1827171e9c19f945e87824215721f8cf22258 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 176 | 35 | 4 | 88247142c6482f3b4fa845d64e6189c690a5ee52 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.37e-05 | 187 | 35 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.40e-05 | 188 | 35 | 4 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 188 | 35 | 4 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 190 | 35 | 4 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 190 | 35 | 4 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 190 | 35 | 4 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 191 | 35 | 4 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 192 | 35 | 4 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Treg|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 192 | 35 | 4 | 0deb6aa323e1de72ee8a2002449e523dd4f0bf5d | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-05 | 193 | 35 | 4 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.55e-05 | 193 | 35 | 4 | d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-05 | 195 | 35 | 4 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-05 | 195 | 35 | 4 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-05 | 196 | 35 | 4 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-T_reg|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 196 | 35 | 4 | 6362fb0b5dc923f19a76b605d7289a16f89220e3 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-05 | 196 | 35 | 4 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-Treg|URO / Disease, condition lineage and cell class | 1.65e-05 | 196 | 35 | 4 | 8812d7365fb2b33feff93782d60776e932499a43 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 196 | 35 | 4 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | medial-mesenchymal-Pericyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | bbda454260016be92b539e220ecf7bcbbc6139e4 | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | medial-mesenchymal-Pericyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | f36d7cb6345daccebf76997f998e35d959b59452 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | medial-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | 9820fb4f6efcdfc6de937ef2302a98b48426baa3 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.00e-04 | 115 | 35 | 3 | 207d464c09caf9be361daa56c83cd7da5cf9ce47 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 130 | 35 | 3 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-04 | 130 | 35 | 3 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.68e-04 | 137 | 35 | 3 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 1.72e-04 | 138 | 35 | 3 | 9f8389a34c400a6b2b9bf6cef3a71499cc945e35 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.99e-04 | 145 | 35 | 3 | e932361734839c14ffa0c1e028dcef9c833f884f | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-04 | 145 | 35 | 3 | 29422c908d58081e6a748e362a7ac41bf001444c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.03e-04 | 146 | 35 | 3 | a4f2e3ea79e7154873c01739672ec6454547e6a6 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_Naive|ICU-SEP / Disease, Lineage and Cell Type | 2.16e-04 | 149 | 35 | 3 | a66f3ebf6214b269b137ddd5f4d8d7fb3ef2d962 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-04 | 153 | 35 | 3 | cda759ab83a271974651fe4faa21ed4f7ecbb3ae | |
| ToppCell | COVID-Treg-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 2.33e-04 | 153 | 35 | 3 | 47c649fd4231e507f2d4654ccac61faf21a04eff | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 2.33e-04 | 153 | 35 | 3 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | COVID-Treg|COVID / Condition, Cell_class and T cell subcluster | 2.47e-04 | 156 | 35 | 3 | a1dd61d4c9ed8f283f0fcbf875c5fd7807ca370d | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 2.47e-04 | 156 | 35 | 3 | 0ea6ca3f38109151a2a4fdf63a4f009929cdcc40 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-04 | 157 | 35 | 3 | f1c6c313836352271033d23efd31b0f0a8a09e02 | |
| ToppCell | Control-Lymphocyte-T_NK-Treg|Control / Disease, Lineage and Cell Type | 2.56e-04 | 158 | 35 | 3 | 260dc209f619e1d17a11cede979636001c749786 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 2.56e-04 | 158 | 35 | 3 | f433bc189f000efa34e8e09ab32b3fa22bcf64c4 | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 2.61e-04 | 159 | 35 | 3 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-04 | 159 | 35 | 3 | 6599707107083af6da092fe8984afc8fd89d2bb8 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-04 | 159 | 35 | 3 | 7065062fce248e0458932a22dfcc25a5b5a70cbd | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.61e-04 | 159 | 35 | 3 | 916d070d099726f22deb71966efccff00f8ea071 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-04 | 161 | 35 | 3 | b24293fdae9637983fcf4f2d4659a3554e00a53f | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 2.71e-04 | 161 | 35 | 3 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.71e-04 | 161 | 35 | 3 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 161 | 35 | 3 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.71e-04 | 161 | 35 | 3 | d0482666479530cd2fd0d229cbb59a1d79839477 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.71e-04 | 161 | 35 | 3 | eddcbe266d4a84a340fa8f2128d2b7e293968dca | |
| ToppCell | COVID-19_Severe-Treg|World / disease group, cell group and cell class | 2.71e-04 | 161 | 35 | 3 | c6eade2c60c572d823e6e81b5e8d47078671e9b0 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_CTL|URO / Disease, Lineage and Cell Type | 2.76e-04 | 162 | 35 | 3 | 1afeeb17e263cf625a4f285203cf82f973735193 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-Treg|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.76e-04 | 162 | 35 | 3 | 975d52e3cc101e7592425128e1099d30847a8a42 | |
| ToppCell | Dendritic_Cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.81e-04 | 163 | 35 | 3 | 5fff3932c1c259010e3add7a3b2301df2fa37df1 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.81e-04 | 163 | 35 | 3 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.86e-04 | 164 | 35 | 3 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | T_cells-TFH-like_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.86e-04 | 164 | 35 | 3 | b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 2.96e-04 | 166 | 35 | 3 | ff32422390852546e0cb216192452e9c47bd9509 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 166 | 35 | 3 | 64a0762eb9cafb6a079df296ed677c8e0ae0efa7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-04 | 167 | 35 | 3 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 3.07e-04 | 168 | 35 | 3 | 76b49463895cdef27c90f831c6246bcb92b9761b | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-04 | 168 | 35 | 3 | 9d6ca10c272aea28082c09d469940f7232f6461c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like|Lung / Manually curated celltypes from each tissue | 3.07e-04 | 168 | 35 | 3 | b9bde6f542d730682d34a80e1f7f1609e5c699c7 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-Treg|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.07e-04 | 168 | 35 | 3 | 99117480687e2b8e7521d3ae9e020791757ec48e | |
| ToppCell | IIF-Lymphocyte-T_NK-Treg|IIF / Disease, Lineage and Cell Type | 3.12e-04 | 169 | 35 | 3 | aac6ff89e0b3bc1f644e6cc6a696360659b254b5 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 3.12e-04 | 169 | 35 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 170 | 35 | 3 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-04 | 170 | 35 | 3 | bda900c836e0f2c1d7b442beb50b672d025b2420 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 3.23e-04 | 171 | 35 | 3 | 0d14bc9688c427ba2265984987dc3eea195b19eb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 35 | 3 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 174 | 35 | 3 | 66a3b20ff1ab9f36fb391986444d7dc99d0c03d1 | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 3.40e-04 | 174 | 35 | 3 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | Healthy_donor-Treg|Healthy_donor / disease group, cell group and cell class (v2) | 3.40e-04 | 174 | 35 | 3 | 1d76921c8404b5be5fbe9f3157d53578033f2ad2 | |
| ToppCell | 356C-Lymphocytic-ILC|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 175 | 35 | 3 | 7fa8330ce813c48bd332be618909e5ec8d0f5d7e | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-04 | 175 | 35 | 3 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | normal_Lung-T/NK_cells-Treg|normal_Lung / Location, Cell class and cell subclass | 3.45e-04 | 175 | 35 | 3 | bc846312e6a6d68b7ca661052fb4e02cfb8ed014 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-04 | 175 | 35 | 3 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 175 | 35 | 3 | d427c1eaea805046b1e4944d374adc7095f710a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 175 | 35 | 3 | b9931455f232de3029510993015bb13b70dc18c9 | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.51e-04 | 176 | 35 | 3 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-04 | 176 | 35 | 3 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-04 | 176 | 35 | 3 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | (1)_T_regulatory|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.57e-04 | 177 | 35 | 3 | 5cda56b10df1ee8971ce8470d52062e01b703a4e | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.57e-04 | 177 | 35 | 3 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 177 | 35 | 3 | d5503605d46a335cc7ca1f94626809f9e1b505e2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.63e-04 | 178 | 35 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 178 | 35 | 3 | 307b6e21bc69a0310c550f1fafa8600285e99ccd | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.63e-04 | 178 | 35 | 3 | 90dedb3cef9b01907b9f8eec64218d6d2072be1f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.63e-04 | 178 | 35 | 3 | d6312286bf6cc5b107ccd7adb583d9667d4e1d21 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-04 | 179 | 35 | 3 | 4e9e0deabf9b09ffcf30fed6d5eae72ce0ef2f1f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.69e-04 | 179 | 35 | 3 | 593fc323b28304a57ae162f64b0890b893fff446 | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; HL60; HT_HG-U133A | 5.72e-06 | 174 | 34 | 5 | 2452_UP | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 9.00e-06 | 191 | 34 | 5 | 1227_UP | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.00e-06 | 191 | 34 | 5 | 6236_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 9.47e-06 | 193 | 34 | 5 | 2294_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 9.95e-06 | 195 | 34 | 5 | 6959_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A | 1.05e-05 | 197 | 34 | 5 | 1386_DN | |
| Drug | Jak2-Inhibitor-II | 3.23e-05 | 6 | 34 | 2 | CID000074603 | |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.07e-04 | 166 | 34 | 4 | 2540_UP | |
| Drug | staurosporine; Up 200; 0.1uM; MCF7; HG-U133A | 1.34e-04 | 176 | 34 | 4 | 423_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.36e-04 | 177 | 34 | 4 | 4652_DN | |
| Drug | 4-chloronitrobenzene | 1.42e-04 | 12 | 34 | 2 | CID000007474 | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.55e-04 | 183 | 34 | 4 | 7062_DN | |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 1.62e-04 | 185 | 34 | 4 | 6082_UP | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.76e-04 | 189 | 34 | 4 | 3165_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.76e-04 | 189 | 34 | 4 | 3262_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.79e-04 | 190 | 34 | 4 | 6274_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; HL60; HT_HG-U133A | 1.79e-04 | 190 | 34 | 4 | 6156_UP | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; PC3; HT_HG-U133A | 1.83e-04 | 191 | 34 | 4 | 5085_DN | |
| Drug | Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 1696_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.90e-04 | 193 | 34 | 4 | 3906_DN | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.90e-04 | 193 | 34 | 4 | 3440_UP | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.90e-04 | 193 | 34 | 4 | 3880_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 6835_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 4648_DN | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 5049_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 7098_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 5241_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 3459_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 2707_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 6643_DN | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 7527_DN | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 2570_UP | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 1338_DN | |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 7208_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 2207_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4439_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 2778_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 5887_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; HL60; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 2363_DN | |
| Drug | ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.06e-04 | 197 | 34 | 4 | 882_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.06e-04 | 197 | 34 | 4 | 1048_UP | |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 7321_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 7275_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5219_DN | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 7127_UP | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 2799_DN | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 6294_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 7023_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 3004_UP | |
| Drug | C070379 | 2.14e-04 | 199 | 34 | 4 | CID003034747 | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 7380_DN | |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 6306_DN | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 1469_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 2618_DN | |
| Drug | 3-(2-hydroxyphenyl)prop-2-enal | 2.25e-04 | 15 | 34 | 2 | CID000098373 | |
| Drug | acenaphthenequinone | 2.90e-04 | 17 | 34 | 2 | CID000006724 | |
| Disease | mean reticulocyte volume | 2.72e-04 | 799 | 34 | 6 | EFO_0010701 | |
| Disease | Thyroid Gland Follicular Adenoma | 7.49e-04 | 35 | 34 | 2 | C0151468 | |
| Disease | Thyroid Neoplasm | 8.37e-04 | 37 | 34 | 2 | C0040136 | |
| Disease | Colorectal Carcinoma | 1.18e-03 | 702 | 34 | 5 | C0009402 | |
| Disease | Thyroid carcinoma | 1.18e-03 | 44 | 34 | 2 | C0549473 | |
| Disease | Liver Cirrhosis, Experimental | 1.82e-03 | 774 | 34 | 5 | C0023893 | |
| Disease | leukemia | 1.84e-03 | 55 | 34 | 2 | C0023418 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TACITVEDAEMMSRM | 231 | Q9Y646 | |
| SEAEAVCDRMAMMVS | 1401 | Q8WWZ4 | |
| MAGSREVVAMDCEMV | 1 | Q96AZ6 | |
| EECLGMAVLDMMRIA | 176 | O60674 | |
| CCGMRNTDVSMENMV | 146 | Q9NPC2 | |
| EETLMFCMRVMVGVI | 246 | Q9H0Q0 | |
| EEAMVQDAEMAMAEC | 361 | Q15139 | |
| NVVGPTMCFEDRMIM | 76 | Q96BQ1 | |
| MATCEMCGMVGVRDA | 51 | Q05BQ5 | |
| MMCEVMPTISEDGRR | 1 | O75145 | |
| IGMEDCETMEDVYMA | 31 | Q9NYS0 | |
| LMERVMMEFVRETCS | 1176 | O60318 | |
| ACYMEEMRHIDMVEG | 236 | P52789 | |
| DMVEGDEGRMCINME | 246 | P52789 | |
| LRVTDCMGREIMTMQ | 176 | Q9NRQ2 | |
| MDMGLREMCVGEKRT | 1 | Q75LS8 | |
| AHFEEMGMCVETDME | 736 | Q9C000 | |
| TETPEMMEARCRKMA | 486 | P52701 | |
| EMMATMCQERGARLF | 271 | Q9NPF4 | |
| DESRQMMVMVEECGR | 56 | Q9Y693 | |
| CMETIGEEISEMRQM | 1146 | Q6PIJ6 | |
| IAPMMERRMECGAVI | 491 | Q8NBE8 | |
| CLIRMGASMRTEEEM | 211 | Q5VT06 | |
| ARVCENCMEMDVMSV | 116 | P07766 | |
| RVMERRGMETCAMET | 431 | Q9H0L4 | |
| RGMETCAMETRGMEA | 436 | Q9H0L4 | |
| CAMETRGMEARGMDA | 441 | Q9H0L4 | |
| EIECTEEEMMMFAAL | 306 | Q96AC1 | |
| MVTMEELREMDCSVL | 1 | Q13115 | |
| GREMGSCMEFKDREM | 271 | P78332 | |
| MIEKMQGSRMDEQRC | 1 | P47736 | |
| EMMQIECEVMDTRVI | 641 | Q99941 | |
| RSFSANMMEESEMCA | 61 | A4UGR9 | |
| GVMEMMVALCGSERE | 421 | Q8IWX7 | |
| MEGMLCRKQEMEAFG | 2221 | O15020 | |
| MAAEDREMMEARGAG | 1 | A6NEH6 | |
| MDGRLERTMEAVCMV | 1731 | A3KMH1 | |
| ERTMEAVCMVMEAFE | 1736 | A3KMH1 | |
| TVDFDEFLVMMVRCM | 71 | P63316 |